Does VEDOLIZUMAB Cause Myocardial infarction? 327 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 327 reports of Myocardial infarction have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.4% of all adverse event reports for VEDOLIZUMAB.
327
Reports of Myocardial infarction with VEDOLIZUMAB
0.4%
of all VEDOLIZUMAB reports
53
Deaths
212
Hospitalizations
How Dangerous Is Myocardial infarction From VEDOLIZUMAB?
Of the 327 reports, 53 (16.2%) resulted in death, 212 (64.8%) required hospitalization, and 14 (4.3%) were considered life-threatening.
Is Myocardial infarction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 327 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Myocardial infarction?
ROSIGLITAZONE (17,018)
TESTOSTERONE (3,396)
ADALIMUMAB (3,214)
SACUBITRIL\VALSARTAN (3,120)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391)
APIXABAN (2,010)
TICAGRELOR (1,749)
LENALIDOMIDE (1,712)
ETANERCEPT (1,693)
METFORMIN\ROSIGLITAZONE (1,640)
Which VEDOLIZUMAB Alternatives Have Lower Myocardial infarction Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB